NME1 and melanoma: In addition, numerous studies analyzing human patients with melanoma or epithelial tumors of the breast, liver, colon or ovary, found that loss of NME1 expression correlated with a greater risk of metastasis and a poorer clinical prognosis [10, 37, 44–49].